These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35541904)

  • 1. The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth.
    Zhang Y; Cheng L; Shi X; Song Y; Chen XY; Chen MB; Yao J; Zhang ZQ; Cai S
    Int J Biol Sci; 2022; 18(7):2994-3005. PubMed ID: 35541904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth.
    Jin L; Zhu J; Yao L; Shen G; Xue BX; Tao W
    Cell Death Dis; 2023 Aug; 14(8):537. PubMed ID: 37604912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V.
    Sun X; Shan HJ; Yin G; Zhang XY; Huang YM; Li HJ
    Cell Death Discov; 2022 Feb; 8(1):48. PubMed ID: 35115496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
    Xu L; Zhang Y; Gao M; Wang G; Fu Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKI-349, a Sphingosine Kinases 1/2 Inhibitor, Suppresses Cell Viability, Invasion, and AKT/mTOR Signaling Pathway, and Shows Synergistic Cytotoxic Effects with Sorafenib in Hepatocellular Carcinoma.
    Chen L; Wang L; Han Z; Qin P; Niu G; Du J
    Tohoku J Exp Med; 2024 Mar; 262(3):173-180. PubMed ID: 38123304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells.
    Yang YL; Ji C; Cheng L; He L; Lu CC; Wang R; Bi ZG
    Cancer Sci; 2012 Aug; 103(8):1538-45. PubMed ID: 22594559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of SphK1 by K6PC-5 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Myocardial Cell Death.
    Shao JJ; Peng Y; Wang LM; Wang JK; Chen X
    DNA Cell Biol; 2015 Nov; 34(11):669-76. PubMed ID: 26308910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation.
    Nemoto S; Nakamura M; Osawa Y; Kono S; Itoh Y; Okano Y; Murate T; Hara A; Ueda H; Nozawa Y; Banno Y
    J Biol Chem; 2009 Apr; 284(16):10422-32. PubMed ID: 19240026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting sphingosine kinase-1 to inhibit melanoma.
    Madhunapantula SV; Hengst J; Gowda R; Fox TE; Yun JK; Robertson GP
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):259-74. PubMed ID: 22236408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.
    Yao C; Wu S; Li D; Ding H; Wang Z; Yang Y; Yan S; Gu Z
    Mol Oncol; 2012 Aug; 6(4):392-404. PubMed ID: 22583777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
    Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW
    Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
    Gao H; Gao MQ; Peng JJ; Han M; Liu KL; Han YT
    Acta Pharmacol Sin; 2017 Dec; 38(12):1618-1631. PubMed ID: 29119970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic value of SC66 in human renal cell carcinoma cells.
    Xu M; Wang Y; Zhou LN; Xu LJ; Jin ZC; Yang DR; Chen MB; Zhu J
    Cell Death Dis; 2020 May; 11(5):353. PubMed ID: 32393791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.
    Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M
    Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor.
    Zhang D; Xia H; Zhang W; Fang B
    Tumour Biol; 2016 Jan; 37(1):1327-36. PubMed ID: 26293898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
    Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
    Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling.
    Ji F; Mao L; Liu Y; Cao X; Xie Y; Wang S; Fei H
    Biochem Biophys Res Commun; 2015 Mar; 458(3):568-575. PubMed ID: 25680461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
    LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
    Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.
    Xun C; Chen MB; Qi L; Tie-Ning Z; Peng X; Ning L; Zhi-Xiao C; Li-Wei W
    J Exp Clin Cancer Res; 2015 Sep; 34(1):94. PubMed ID: 26337959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.